Robert Torray’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,394
Closed -$856K 105
2018
Q3
$856K Buy
7,394
+140
+2% +$15.8K 0.09% 89
2018
Q2
$916K Sell
7,254
-324
-4% -$39.4K 0.1% 84
2018
Q1
$820K Buy
7,578
+151
+2% +$16.7K 0.09% 88
2017
Q4
$814K Buy
7,427
+2,995
+68% +$299K 0.08% 87
2017
Q3
$437K Buy
4,432
+38
+0.9% +$3.68K 0.04% 102
2017
Q2
$445K Buy
4,394
+528
+14% +$56.9K 0.05% 98
2017
Q1
$447K Sell
3,866
-3,875
-50% -$450K 0.05% 92
2016
Q4
$929K Buy
+7,741
New +$857K 0.1% 80
2015
Q1
Sell
-138,338
Closed -$16.6M 68
2014
Q4
$16.6M Buy
138,338
+11,965
+9% +$1.57M 1.4% 29
2014
Q3
$18.5M Buy
126,373
+29,260
+30% +$4.52M 1.68% 26
2014
Q2
$16.2M Buy
97,113
+65,890
+211% +$11.7M 1.64% 26
2014
Q1
$6.2M Buy
31,223
+13,700
+78% +$2.59M 1.05% 53
2013
Q4
$3.35M Sell
17,523
-445
-2% -$82.8K 0.69% 52
2013
Q3
$3.04M Buy
17,968
+23
+0.1% +$3.57K 0.66% 52
2013
Q2
$2.72M Buy
+17,945
New +$2.54M 0.59% 55

Other funds holding CLB

Robert Torray's CLB Position: Q4 2018 in Review

Robert Torray sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 7,394 shares — an estimated $856K sold.

Robert Torray first reported a position in CLB in Q2 2013 and held it in 15 quarters. The position peaked at $18.5M in Q3 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Robert Torray reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Robert Torray sold 7,394 Core Laboratories shares in Q4 2018, an estimated $856K.
  • Robert Torray first reported a position in Core Laboratories in Q2 2013 and held it in 15 quarters.
  • Robert Torray's Core Laboratories position peaked at $18.5M in Q3 2014.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Torray Investment Partners's 13F filing for Q4 2018, filed 6 Feb 2019.